Journal for ImmunoTherapy of Cancer (Nov 2023)

1286 A novel gene signature predicts immune infiltration phenotypes in humanized patient derived xenograft models

Stefano Cairo,
Maria Mancini,
Mara Gilardi,
Karin Abarca Heidemann,
Michael Ritchie,
Christine Baer,
Gilad Silberberg,
Marianna Zipeto,
Hsiu-Wen Tsai,
Kurtis Cruz

Affiliations

Stefano Cairo: Champions Oncology, Hackensack, NJ, USA
Maria Mancini: Champions Oncology, Hackensack, NJ, USA
Mara Gilardi: Champions Oncology, Hackensack, NJ, USA
Karin Abarca Heidemann: Champions Oncology, Hackensack, NJ, USA
Michael Ritchie: Champions Oncology, Hackensack, NJ, USA
Christine Baer: Champions Oncology, Hackensack, NJ, USA
Gilad Silberberg: Champions Oncology, Hackensack, NJ, USA
Marianna Zipeto: Champions Oncology, Hackensack, NJ, USA
Hsiu-Wen Tsai: Champions Oncology, Hackensack, NJ, USA
Kurtis Cruz: Champions Oncology, Hackensack, NJ, USA

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.1286
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal